The strains used in this study are described in
Table 1. For general maintenance,
K.
pneumoniae and
P.
aeruginosa were grown at 37°C overnight in
Hy-Soy (HS) bacteriological media (5 g/L sodium chloride, 10 g/L
soytone [Teknova, CA], 5 g/L
Hy-yest [Sigma Aldrich, MO]) at 37°C. 1.5%
bacteriological agar (AmericanBio, MA) was added to HS for solid media preparations. Fully chemically defined medium (CDM) used for growth of KP in fermentation cultures and to assess
guanine auxotrophy has been described previously [19 (
link)]. 0.004%-0.025%
guanine (Sigma Aldrich, MO) was added for the growth of CVD 3001 to supplement the
guaBA mutation. O types were determined by PCR with extracted genomic DNA as described [14 (
link)]. K types were determined by sequencing of the
wzi or
wzc genes, or multiplex PCR [20 (
link)–22 (
link)].
Hegerle N., Choi M., Sinclair J., Amin M.N., Ollivault-Shiflett M., Curtis B., Laufer R.S., Shridhar S., Brammer J., Toapanta F.R., Holder I.A., Pasetti M.F., Lees A., Tennant S.M., Cross A.S, & Simon R. (2018). Development of a broad spectrum glycoconjugate vaccine to prevent wound and disseminated infections with Klebsiella pneumoniae and Pseudomonas aeruginosa. PLoS ONE, 13(9), e0203143.